• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
 
Generic Name:  chenodiol
Date Designated:  03/22/2010
Orphan Designation:  Treatment of cerebrotendinous xanthomatosis
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
Travere Therapeutics, Inc.
3611 Valley Centre Drive, Suite 300
San Diego, California 92130
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-